Clinical Trials Logo

Parotid Neoplasms clinical trials

View clinical trials related to Parotid Neoplasms.

Filter by:

NCT ID: NCT05738395 Recruiting - Parotid Neoplasms Clinical Trials

Symptoms of Frey's Syndrome

Start date: November 1, 2020
Phase:
Study type: Observational

The goal of this observational study is to describe the prevalence of typical and atypical signs and symptoms of Frey's syndrome, the affected areas and the severity of each symptom/sign. Participants will be asked will asked about - Presence or the absence of: a. gustatory sweating; b. gustatory flushing; c. gustatory itching; d. paresthesia; e. pain - Grade of severity: a. absence; b. mild; c. moderate; d. almost severe; e. severe - Affected area: a. preauricular; b. retroauricolar; c. temporal; d. retrangulomandibular; e. cheek

NCT ID: NCT05505318 Recruiting - Clinical trials for Parotid Gland Neoplasm

Pattern and Surgical Treatment of Parotid Gland Neoplasms

Start date: May 20, 2015
Phase:
Study type: Observational

in these study we analyze pattern of parotid gland neoplasms according to histopathological types, most common type clinical presentation and type of surgical treatment(superficial parotidectomy or total parotidectomy radical parotidectomy

NCT ID: NCT05401370 Not yet recruiting - Parotid Tumor Clinical Trials

Role of Methylene Blue in Parotid Surgery

Start date: June 2022
Phase: N/A
Study type: Interventional

usefulness of the methylene blue staining for identification of facial nerve in parotid gland surgery

NCT ID: NCT05296109 Recruiting - Parotid Neoplasms Clinical Trials

Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Parotid neoplasm consists of a wide range of benign and malignant lesions, and parotidectomy has been the mainstay for management of these neoplasms. Within the parotid gland there are branches of the intra-parotid facial nerves, which are tiny in calibre and are prone to injury to injury during operation. It has been reported in recent retrospective view that the incidence of temporary and permanent facial nerve injury were 9.2% and 5.2% respectively, the risk of which increased with old age, malignant tumour and revision surgery. Traditional the incidental of facial nerve injury is reduced by intra-operative facial nerve monitoring and surgical magnification, while imaging has limited role in aiding this purpose. However with advancement in MRI technique high resolution three-dimensional sequences (i.e. neurogram sequences) are available for better visualization of branches of facial nerves. The investigators would therefore aim to demonstrate additional efficacy of these techniques and also to compare with conventional 3D post-contrast anatomical imaging studies in the localization and visualization of the facial nerve branches in patients with tumour. With better pre-operative imaging, the investigators hope to reduce the chance of facial nerve injury in these patients.

NCT ID: NCT05221736 Recruiting - Clinical trials for Warthin's Tumor of Parotid Gland

Management of Warthin Tumor of Parotid Gland.

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Comparison between Ultrasound-Guided Ethanol Sclerotherapy (UGES) & surgical excision in management of warthin tumor of parotid gland.

NCT ID: NCT05152056 Completed - Parotid Tumor Clinical Trials

MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Parotid
Start date: November 15, 2021
Phase:
Study type: Observational

What value is given to MRI diffusion and perfusion sequences in the diagnosis of parotid tumors? Is a fine needle aspiration associated with MRI systematically necessary? The aim of the research is to study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases.

NCT ID: NCT04870762 Recruiting - Clinical trials for Head and Neck Carcinoma

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Start date: May 26, 2021
Phase: Phase 2
Study type: Interventional

This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy. A customized, 3D-printed oral stent may help to reduce mouth blisters and/or sores that may develop in patients while receiving head and neck radiation therapy.

NCT ID: NCT04803032 Completed - Surgery Clinical Trials

Trident Landmark as a Safe and Easy Method for Facial Nerve Trunk Identification During Superficial Parotidectomy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The parotid has a close relationship with the extra temporal course of the facial nerve. The study aimed to evaluate the accuracy and safety of trident landmark during superficial parotidectomy in the identification of the facial nerve trunk.

NCT ID: NCT04613349 Recruiting - Parotid Tumor Clinical Trials

FArial NErf MRI in the Preoperative Assessment of PArotide Tumors

NEFAPA
Start date: January 13, 2021
Phase:
Study type: Observational

1. st visit: Inclusion, 3Tesla injected parotid MRI performed as part of routine care for characterization, to which two specific high resolution sequences will be added. Evaluation of the exact position of the parotid tumor relative to the trunk of the facial nerve and its first branches, classification into two categories: on contact (≤ 5 mm) or at a distance (> 5 mm). 2. nd visit: Surgical intervention of the parotid tumor. The surgeon will specify the same data as that collected by the radiologists after the MRI. 3. rd visit: Post-operative consultation in the week following the intervention. The surgeon will look for the occurrence of post-operative facial paralysis.

NCT ID: NCT04420689 Completed - Surgery Clinical Trials

A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Start date: June 18, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1/2 study of ALM-488 to highlight nerves in patients undergoing head & neck surgery.